Your Health, We Care
The authoritative journal Kidney International published the ASCEND-NHQ study, which showed that the quality of life of patients in the dacomitinib group was significantly higher than that of the placebo group.
With the progress of regulatory approval of dacomitinib worldwide, its clinical application will become more widespread. Especially in markets such as Japan, Europe, and the United States, dacomitinib is expected to become an important drug for treating renal anemia.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
